CSL Ltd. CSL
Dividend Summary
The next CSL Ltd. dividend is expected to go ex in 3 months and to be paid in 3 months.
The previous CSL Ltd. dividend was 217.4599999999999c and it went ex 3 months ago and it was paid 3 months ago.
There are typically 2 dividends per year (excluding specials), and the dividend cover is approximately 2.0.
| Summary | Previous dividend | Next dividend |
|---|---|---|
| Status | Paid | Forecast |
| Type | Final | Interim |
| Per share | 217.46c (145c) | Sign Up Required |
| Declaration date | 13 Aug 2024 (Tue) | 11 Feb 2025 (Tue) |
| Ex-div date | 09 Sep 2024 (Mon) | 10 Mar 2025 (Mon) |
| Pay date | 02 Oct 2024 (Wed) | 02 Apr 2025 (Wed) |
Enter the number of CSL Ltd. shares you hold and we'll calculate your dividend payments:
Sign up for CSL Ltd. and we'll email you the dividend information when they declare.
Add CSL Ltd. to receive free notifications when they declare their dividends.
Your account is set up to receive CSL Ltd. notifications.
| Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
|---|---|---|---|---|---|---|---|---|
| Forecast | Final | 07 Aug 2029 | 03 Sep 2029 | 26 Sep 2029 | USD | Sign up | — | |
| Forecast | Interim | 06 Feb 2029 | 05 Mar 2029 | 28 Mar 2029 | USD | Sign up | — | |
| Forecast | Final | 08 Aug 2028 | 04 Sep 2028 | 27 Sep 2028 | USD | Sign up | — | |
| Forecast | Interim | 08 Feb 2028 | 06 Mar 2028 | 29 Mar 2028 | USD | Sign up | — | |
| Forecast | Final | 10 Aug 2027 | 06 Sep 2027 | 29 Sep 2027 | USD | Sign up | — | |
| Forecast | Interim | 09 Feb 2027 | 08 Mar 2027 | 31 Mar 2027 | USD | Sign up | — | |
| Forecast | Final | 11 Aug 2026 | 07 Sep 2026 | 30 Sep 2026 | USD | Sign up | — | |
| Forecast | Interim | 10 Feb 2026 | 09 Mar 2026 | 01 Apr 2026 | USD | Sign up | — | |
| Forecast | Final | 12 Aug 2025 | 08 Sep 2025 | 01 Oct 2025 | USD | Sign up | — | |
| Forecast | Interim | 11 Feb 2025 | 10 Mar 2025 | 02 Apr 2025 | USD | Sign up | — | |
| Paid | Final | 13 Aug 2024 | 09 Sep 2024 | 02 Oct 2024 | USD | 143c | 145c | 😃 |
| Paid | Interim | 13 Feb 2024 | 11 Mar 2024 | 03 Apr 2024 | USD | 110c | 119c | 😊 |
| Paid | Final | 15 Aug 2023 | 11 Sep 2023 | 04 Oct 2023 | USD | 121c | 129c | 😊 |
| Paid | Interim | 14 Feb 2023 | 09 Mar 2023 | 05 Apr 2023 | USD | 109c | 107c | 😃 |
| Paid | Final | 17 Aug 2022 | 06 Sep 2022 | 05 Oct 2022 | USD | — | 118c | |
| Paid | Interim | 16 Feb 2022 | 07 Mar 2022 | 06 Apr 2022 | USD | — | 104c | |
| Paid | Final | 18 Aug 2021 | 02 Sep 2021 | 30 Sep 2021 | USD | — | 118c | |
| Paid | Interim | 18 Feb 2021 | 04 Mar 2021 | 01 Apr 2021 | USD | — | 104c | |
| Paid | Final | 19 Aug 2020 | 10 Sep 2020 | 09 Oct 2020 | USD | — | 107c | |
| Paid | Interim | 12 Feb 2020 | 11 Mar 2020 | 09 Apr 2020 | USD | — | 95c | |
| Paid | Final | 14 Aug 2019 | 10 Sep 2019 | 11 Oct 2019 | USD | — | 100c | |
| Paid | Interim | 13 Feb 2019 | 13 Mar 2019 | 12 Apr 2019 | USD | — | 85c | |
| Paid | Final | 15 Aug 2018 | 11 Sep 2018 | 12 Oct 2018 | USD | — | 93c | |
| Paid | Interim | 14 Feb 2018 | 14 Mar 2018 | 13 Apr 2018 | USD | — | 79c | |
| Paid | Final | 16 Aug 2017 | 12 Sep 2017 | 13 Oct 2017 | USD | — | 72c | |
| Paid | Interim | 15 Feb 2017 | 15 Mar 2017 | 13 Apr 2017 | USD | — | 64c | |
| Paid | Final | 17 Aug 2016 | 13 Sep 2016 | 07 Oct 2016 | USD | — | 68c | |
| Paid | Interim | 16 Feb 2016 | 23 Mar 2016 | 15 Apr 2016 | USD | — | 58c | |
| Paid | Final | 12 Aug 2015 | 07 Sep 2015 | 02 Oct 2015 | USD | — | 66c | |
| Paid | Interim | 11 Feb 2015 | 16 Mar 2015 | 10 Apr 2015 | USD | — | 58c | |
| Paid | Final | – | 08 Sep 2014 | 03 Oct 2014 | USD | — | 60c | |
| Paid | Interim | 12 Feb 2014 | 05 Mar 2014 | 04 Apr 2014 | USD | — | 53c | |
| Paid | Final | – | 09 Sep 2013 | 04 Oct 2013 | USD | — | 52c | |
| Paid | Interim | – | 05 Mar 2013 | 05 Apr 2013 | AUD | — | 48.66c | |
| Paid | Final | – | 17 Sep 2012 | 12 Oct 2012 | AUD | — | 47c | |
| Paid | Interim | – | 14 Mar 2012 | 13 Apr 2012 | AUD | — | 36c |
| Year | Amount | Change |
|---|---|---|
| 2006 | 0.0c | — |
| 2007 | 0.0c | 0% |
| 2008 | 0.0c | 0% |
| 2009 | 0.0c | 0% |
| 2010 | 0.0c | 0% |
| 2011 | 0.0c | 0% |
| 2012 | 83.0c | 100% |
| 2013 | 105.64c | 27.3% |
| 2014 | 123.73c | 17.1% |
| 2015 | 164.38c | 32.9% |
| 2016 | 170.14c | 3.5% |
| 2017 | 175.31c | 3.0% |
| 2018 | 228.32c | 30.2% |
| 2019 | 265.77c | 16.4% |
| 2020 | 294.09c | 10.7% |
| 2021 | 293.88c | -0.1% |
| 2022 | 318.12c | 8.2% |
| 2023 | 362.93c | 14.1% |
| 2024 | Sign Up Required | |
| 2025 | Sign Up Required | |
| 2026 | Sign Up Required | |
| 2027 | Sign Up Required | |
| 2028 | Sign Up Required | |
| 2029 | Sign Up Required | |
CSL Ltd. Optimized Dividend Chart
- Dividend Yield Today
- 1.4%
- Optimized Yield
- Sign Up Required
- 52 Week High
- 2.1% on 07 September 2024
- 52 Week Low
- 1.4% on 12 September 2024
- Next Ex-Div-Date Countdown
- Sign Up Required
About CSL Ltd.
CSL Limited (CSL) is a biotechnology company engaged in developing and delivering biotherapies and influenza vaccines that treat people with serious diseases and chronic medical conditions. CSL provides a portfolio of life saving medicines, including those that treat hemophilia and immune deficiencies, as well as vaccines to prevent influenza. Its segments include CSL Behring and Seqirus. CSL Behring manufactures, markets, and develops plasma therapies (plasma products and recombinants), conducts early-stage research on plasma and non-plasma therapies, excluding influenza, receives license and royalty income from the commercialization of intellectual property and undertakes the administrative and corporate function required to support the Company. Seqirus manufactures and distributes non-plasma biotherapeutic products and develops influenza related products. CSL’s products include HIZENTRA, PRIVIGEN, IDELVION, HAEMATE, KCENTRA, HAEGARDA, ZEMAIRA/RESPREEZA, FLUAD and FLUCELVAX.
- Sector
- Pharmaceuticals & Biotechnology
- Country
- Australia
- Share Price
- AU$276.57 (yesterday's closing price)
- Shares in Issue
- 484 million
- Market Cap
- AU$133.9bn
- 2.0
- 3
- Market Indices
- none
